News How the Polsky Center Helped Zelia Bridge the Gap Between Fashion and Tech AI is seemingly everywhere, so why not your closet? Zelia, an AI-powered personal stylist and shopper, aims to bridge the gap between the fashion and the tech worlds. Through its...
News Eight Graduating Students Receive Polsky Founders’ Fund Fellowships to Work On Their Ventures Full-Time The Polsky Center for Entrepreneurship and Innovation is pleased to announce the eight recipients of the 2023 Polsky Founders’ Fund Fellowship (PF3), a program that provides funding to graduating UChicago...
Program Past Participants 2025 Folasade Rancie – Doulala Michael Gustafson – Three Pillars Sudanshu Kaushik – Exalt Data Randel Bennett – Qixent Laurel Alpaugh – Coclo Ritu Sreenivasan – Mooj Foods Shikhar Pandey…
Page Where Are They Now? Episode 4 Episode 4: Simple Mills May 6, 2021 Katlin Smith, founder and CEO of Simple Mills, wowed her first buyer with a muffin recipe using almond flour. Now the Chicago-based natural...
News Microbiome Research Symposium Highlights Potential of Research-backed Startups to Impact Patient Care Scientists, faculty, entrepreneurs and researchers gathered at UChicago’s Microbiome Research Symposium on April 16 at the Logan Center for the Arts.
News DeepTechU Day 1: Experts Talk Streamlining Tech Transfer, Accelerating Startup Success, and the Importance of Making Connections Juan de Pablo, Vice President for National Laboratories, Science Strategy, Innovation, and Global Initiatives at the University of Chicago, kicked off the first day of DeepTechU – which attracted a global...
News Growth of Private Equity in a Challenging Environment: the 23rd Annual Private Equity Conference Last week the Polsky Center and the Chicago Booth Private Equity Group hosted the 23rd annual Private Equity Conference, bringing investors, students, and entrepreneurs together to network and share insights...
News 22 Teams From Across Campus Explore Commercial Potential of New Ideas More than 20 teams participated in the Polsky Center I-Corps program this academic year – all with new research and ideas addressing challenges across various industries. The goal of the...
Technology Tumor-Specific Cancer Vaccine Adjuvant Formulation Many cancer vaccines fail due to insufficient CD8+ T cell targeting. To save patient lives, oncologists need tumor-specific vaccines that increase CD8+ T cell response. The inventors developed and validated…
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
